Reuterin promotes pyroptosis in hepatocellular cancer cells through mtDNA-mediated STING activation and caspase 8

Lin Cui1, Xiaohui Xu1, Hui Fan1

  • 1Department of Biochemistry and Molecular Biology, and Molecular Medicine and Cancer Research Center, College of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016, China.

Cancer Letters
|August 17, 2024
PubMed

Insights

Reuterin, a metabolite from Lactobacillus reuteri, shows potential against hepatocellular carcinoma (HCC) by inducing cell death. It may enhance sorafenib treatment for liver cancer.

Area of Science:

  • Oncology
  • Microbiology
  • Immunology

Background:

  • Hepatocellular carcinoma (HCC) presents a significant clinical challenge due to limited treatment options and poor prognosis.
  • There is a critical need for novel therapeutic strategies, including new drugs and combination therapies, to combat advanced HCC.

Purpose of the Study:

  • To investigate the anti-HCC potential of reuterin, a metabolite of Lactobacillus reuteri.
  • To elucidate the molecular mechanisms underlying reuterin's anti-tumor effects and its synergy with sorafenib.

Main Methods:

  • Assessing reuterin's impact on HCC cell viability and death pathways.
  • Analyzing the effects of reuterin on mitophagy, mitochondrial DNA (mtDNA) replication, mitochondrial fission, and STING activation.
  • Investigating the roles of caspase 8 and RIPK3 in reuterin-induced cell death.

Main Results:

  • Reuterin demonstrated significant anti-HCC potential, impairing mitophagy and mtDNA replication.
  • Reuterin induced STING activation, leading to pyroptosis and necroptosis, with pyroptosis being the predominant cell death pathway.
  • Reuterin treatment upregulated caspase 8, which cleaved RIPK3, thereby inhibiting necroptosis and promoting pyroptosis.

Conclusions:

  • Reuterin exhibits potent anti-cancer properties against HCC by disrupting mitochondrial function and activating STING-mediated cell death.
  • Reuterin's mechanism involves promoting pyroptosis as the primary mode of cancer cell death.
  • Reuterin holds promise as a combinational therapeutic agent for HCC, potentially enhancing existing treatments like sorafenib.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.4K